This Meningitis B vaccine approval, for use on babies as young as 2 months old, is looking decidedly dodgy to me. > https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/294245/JCVI_Statement_on_MenB.pdf …
-
-
Replying to @C7RKY
>"The vaccine was highly unlikely to demonstrate cost-effectiveness at any price (i.e. even at £0 per dose..unlikely to be cost-effective)"
1 reply 0 retweets 0 likes -
Replying to @C7RKY
>" new & recently published evidence & info on additional parameters, such as litigation costs to the NHS..which had not been included..."
1 reply 0 retweets 0 likes -
Replying to @C7RKY
>"Such parameters, whilst not routinely included in such analyses, are permitted under the NICE methodology" Twisting the rules to suit?!?
1 reply 0 retweets 0 likes -
Replying to @C7RKY
>And all this for a vaccine programme to protect against a disease that has halved in the last 10 years, without medical intervention? Why??
2 replies 0 retweets 0 likes
"JCVI agreed that short term vaccine efficacy against disease of 95%...was a plausible estimate of efficacy" WHAT?? They're making this up!!
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.